Therapeutic human mirnas for use as anti-viral drugs for influenza a infection prophylaxis

Ended Awarded Last action

Contract number
0034
Awardee
Awarding agency
Obligated
$207,900

Award facts

Contract value 100% obligated
$207,899.54 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
Air Force Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition Basic Research
Pricing
Cost Plus Fixed Fee
Place of performance
Houston, TX 77058, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope 4 · Quasar - finalized incremental funding $1,656
Supplemental Agreement for work within scope 3 · To 34 therapeutic human mirnas for use as anti-viral drugs for influenza infection prophylaxis - FIN -$9
Supplemental Agreement for work within scope 2 · Therapeutic human mirnas ncte $0
Other Administrative Action 1 · Therapeutic human mirnas for use as anti-viral drugs - administered by dodaac correction $0
Original award $206,244

About this award

The U.S. Air Force awarded a delivery order valued at $207,899.54 to KBR Wyle Services LLC (doing business as Stinger Ghaffarian Technologies, Inc.) on June 11, 2015, under the QUASAR finalized incremental funding vehicle. The contract, which extends through March 25, 2025, supports research and development of therapeutic human microRNAs intended for use as antiviral drugs for influenza A infection prophylaxis. Performed in Houston, Texas, the effort employs a cost-plus fixed fee pricing structure with no set-aside designation. This work aligns with the Air Force's biomedical research priorities and represents a specialized medical countermeasures development initiative.

KBR Wyle Services, a for-profit technical and professional services provider registered in the System for Award Management since 2002, brings substantial relevant experience to this engagement. The contractor has received over $170 million in prime federal contract awards since 2019, including work for the Department of the Air Force and U.S. Special Operations Command in medical research, operational support, and technical services. As a child entity within a larger corporate structure, KBR Wyle also maintains active subcontracting relationships with major defense contractors including Science Applications International Corporation and Teledyne Brown Engineering, positioning it well to coordinate interdisciplinary expertise for complex biomedical research initiatives.

Quick answers

Who was awarded contract 0034?

0034 was awarded to KBR Wyle Services, LLC by Air Force Research Laboratory (Air Force Materiel Command) on June 11, 2015.

How much is contract 0034 worth?

The government has obligated $207,900 on 0034.

Which agency awarded contract 0034?

Air Force Research Laboratory (Air Force Materiel Command) awarded 0034, with funding from Air Force (Department of Defense).

Is contract 0034 an order under another contract?

Yes. 0034 is a delivery order under FA865012D6280, an indefinite delivery contract.

Was contract 0034 competed?

The extent of competition for 0034 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award